02315 BIOCYTOGEN-B
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 2.31X | Oper Margin | 20.4% |
|---|---|---|---|
| LT Debt/Equity | 16.4% | Net Margin | 12.6% |
| Total Debt/Equity | 43.3% | Return on Equity | 8.0% |
| Price/Book | 11.72X | Return on Assets | 4.7% |
| (HKD 63.500) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | 192.79 | 35.67 | -422.09 | -674.90 | -667.29 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +440.5 | +108.5 | +37.5 | -1.1 | -158.8 |
| Earnings Per Share (HKD) | 0.482 | 0.09 | -1.06 | -1.771 | -1.841 |
| Earnings Per Share Growth (%) | +437.8 | +108.5 | +40.2 | +3.8 | +7.8 |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
| P/E* (X) | 131.77 | 708.71 | N/A | N/A | N/A |
| Yield (%) | N/A | N/A | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
| Book NAV (HKD) | 5.417 | 2.221 | 2.169 | 3.218 | N/A |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 1,379 | 980.454 | +40.6 | 716.912 |
| Operating Result | 210.336 | 72.581 | +189.8 | -371.961 |
| Associates | -22.306 | -29.753 | -25.0 | -10.027 |
| Profit Before Taxation | 188.03 | 42.94 | +337.9 | -380.156 |
| Taxation | 14.831 | 9.403 | +57.7 | 2.796 |
| Profit /( Loss) After Taxation | 173.199 | 33.537 | +416.4 | -382.952 |
| Minority Interests | 0 | -0.005 | -100.0 | -0.001 |
| Net Profit | 173.199 | 33.542 | +416.4 | -382.951 |
| Earnings Per Share () | 0.4819 | 0.0896 | +437.8 | -1.0597 |
| Announcement Date | 2026-03-26 | 2025-03-26 | NA | 2024-03-27 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
